Ioannou Petros, Ziogou Afroditi, Giannakodimos Ilias, Giannakodimos Alexios, Baliou Stella, Samonis George
School of Medicine, University of Crete, 71003 Heraklion, Greece.
School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Antibiotics (Basel). 2024 Jan 4;13(1):53. doi: 10.3390/antibiotics13010053.
Bacteria of the genus are microaerophilic or aerotolerant anaerobic Gram-positive non-spore-forming rods. They are considered essential members of the human gut microbiome; however, recent studies have revealed that these microorganisms are less predominant in the gut microbiome than initially thought. spp. is mainly known for its use as a probiotic in foods and supplements to prevent and treat specific issues such as infectious diseases, irritable bowel syndrome, and diabetes mellitus. However, spp. may occasionally cause infections such as bacteremia or infective endocarditis (IE). The present study aimed to review all cases of IE by spp. and describe the epidemiology, microbiology, clinical characteristics, treatment, and outcomes of this infection by collecting relevant data from studies existing in Pubmed and Scopus until 28 September 2023. A total of 77 studies containing data for 82 patients were included. The median age was 56 years, and 69.6% were male. A prosthetic valve was present in 16% of patients, and 17.3% had previously been on probiotics. The aortic valve was the most commonly involved intracardiac site, followed by the mitral valve. Fever, embolic phenomena, sepsis, and heart failure were the most common clinical presentations. Aminoglycosides and penicillin were the most commonly used antimicrobials for definitive treatment. Surgery was performed in 53.7% of patients. Overall mortality was 17.1%. IE in prosthetic valves and presentation with shock were independently associated with overall mortality.
属细菌为微需氧或耐氧厌氧革兰氏阳性无芽孢杆菌。它们被认为是人类肠道微生物群的重要成员;然而,最近的研究表明,这些微生物在肠道微生物群中的占比低于最初的认知。 种主要因其作为益生菌用于食品和补充剂中,以预防和治疗特定问题(如传染病、肠易激综合征和糖尿病)而闻名。然而, 种偶尔也可能引起感染,如菌血症或感染性心内膜炎(IE)。本研究旨在回顾所有由 种引起的IE病例,并通过收集截至2023年9月28日在Pubmed和Scopus上现有研究中的相关数据,描述这种感染的流行病学、微生物学、临床特征、治疗方法及预后。共纳入77项包含82例患者数据的研究。患者中位年龄为56岁,男性占69.6%。16%的患者有人工瓣膜,17.3%的患者此前使用过益生菌。主动脉瓣是最常受累的心内部位,其次是二尖瓣。发热、栓塞现象、败血症和心力衰竭是最常见的临床表现。氨基糖苷类和青霉素是最常用于确定性治疗的抗菌药物。53.7%的患者接受了手术。总体死亡率为17.1%。人工瓣膜性IE和伴有休克的表现与总体死亡率独立相关。